Improving STING Agonist Delivery for Cancer Immunotherapy Using Biodegradable Mesoporous Silica Nanoparticles is a research paper published in Advanced Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK125087
National Institute of Allergy and Infectious Diseases
Grant: R01AI127070
National Institute of Biomedical Imaging and Bioengineering
Grant: R01EB022563
National Cancer Institute
Grant: R01CA210273
National Cancer Institute
Grant: U01CA210152
National Cancer Institute
Grant: R01CA223804
NIAID NIH HHS
Grant: R56 AI127070
NIDCR NIH HHS
Grant: T32 DE007057
NIGMS NIH HHS
Grant: T32 GM145304
NIGMS NIH HHS
Grant: T32 GM008353
NIAID NIH HHS
Grant: HHSN272201300006C
FWCI
1.50
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals